Prostate cancer (PC) is one of the most common tumors and a leading cause of mortality
among men, resulting in~ 375 000 deaths annually worldwide. Various analytical methods …

One of the most studied topics in analytical chemistry and physics is to develop bio-sensors.
Aptamers are small single-stranded RNA or DNA oligonucleotides (5–25 kDa), which have …

Prostate cancer (PCa) is the second most common male cancer and is attributable to over
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …

This paper focuses on the current state of art as well as on future trends in electrochemical
aptasensors application in medical diagnostics. The origin of aptamers is presented along …

Prostate cancer (PCa), the second most malignant neoplasm in men, is also the fifth leading
cause of cancer-related deaths in men globally. Unfortunately, this malignancy remains …

The conjugation of nanoparticles with antibodies has been successfully applied in sandwich
immunoassays for detecting cancer biomarkers. However, two antibodies are necessary to …

Since prostate cancer (PCa) relies on limited diagnosis and therapies, more effective
alternatives are needed. Aptamers are versatile tools that may be applied for better clinical …

Here we described an aptasensor based on graphene oxide (GO) decorated with gold
nanoparticles (AuNPs) able to detect the AR released by prostate cells, in order to provide …

Studies indicate a potential 108% increase in incidence and 112% in mortality rate of
prostate cancer in Sub-Saharan Africa by 2040. Electrochemical sensors show promise as …

In this paper, a label-free electrochemical immunosensor for sensitive detection of prostate
antigen (PSA) was developed based on a NiFe PBA/AuNPs composite. The prostate antigen …